- gsearch

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

- gsearch

Search Results

Narrow Results:

2024 1

Japan 1

Journal Article 1

Dispatch 1

1 Results

Refine Results

All Collections

Refine Results:

All Collections

Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023

CITE Title : Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023 Personal Author(s) : Kinoshita, Ryo;Miyamoto, Sho;Sakuraba, Shoko;Sugihara, Jun;Suzuki, Motoi;Suzuki, Tadaki;Yoneoka, Daisuke; Published Date : 6 2024 Source : Emerg Infect Dis. 2024; 30(6):1267-1270 URL : https://stacks.cdc.gov/view/cdc/156981 Kinoshita, Ryo et al. (2024). Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023. 30(6). Kinoshita, Ryo et al. "Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023" 30, no. 6 (2024) Kinoshita, Ryo et al. "Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023" vol. 30, no. 6, 2024 Export RIS Citation Information.

:

Kinoshita, Ryo ;

Miyamoto, Sho

6 2024 | Emerg Infect Dis. 2024; 30(6):1267-1270

:

We assessed SARS-CoV-2 seroprevalence in Japan during July-August 2023, with a focus on 2 key age groups, 0-15 and >80 years. We estimated overall ser...

To see more results, try removing search filters or changing the search terms